MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Oxidative stress"

  • 2018 International Congress

    Surface mechanised nano-formulation of naringenin as adenosine A2A receptor antagonist against in Neurological associated problem of Parkinson

    V. Kumar (Allahabad, India)

    Objective: In the current experimental study, we intended to develop Surface mechanized nano-formulation of naringenin (NG) as potent A(2A)AR antagonists against parkinson’s disease. Background: One…
  • 2018 International Congress

    Sex differences by design and outcome in the Safety of Urate Elevation in PD (SURE-PD) trial

    M. Schwarzschild, E. Macklin, R. Bakshi, S. Bhattacharyya,, R. Logan, A. Ascherio; on behalf of the Parkinson Study Group SURE-PD Investigators (Boston, MA, USA)

    Objective: To investigate whether women and men with Parkinson's disease (PD) may differ in their biochemical and clinical responses to long-term treatment with urate-elevating inosine.…
  • 2018 International Congress

    Curcumin improves cognitive function in rotenone-induced rat model of Parkinson’s disease (PD)

    S. Madiha, S. Haider (Karachi, Pakistan)

    Objective: In this study, we aimed to investigate the neuroprotective effect of curcumin against rotenone-induced memory impairments in rat PD model. Background: In PD, oxidative…
  • 2018 International Congress

    Resistance to Parkinson’s disease among LRRK2 mutation carriers is associated with higher plasma levels of urate but not its purine precursors

    M. Schwarzschild, R. Bakshi, R. Logan, M. Zorlu, X. Chen, A. Ascherio, E. Macklin (Boston, MA, USA)

    Objective: To determine whether plasma purine concentrations differ between people with Parkinson's disease (PD) and matched controls among carriers of pathogenic mutations in Leucine-Rich Repeat…
  • 2018 International Congress

    MANF improves the MPP+/MPTP-induced Parkinson’s disease via improvement of mitochondrial function and inhibition of oxidative stress

    Y. Liu, J. zhang, Q. Cai, H. Sun, L. Jin (Shanghai, China)

    Objective: This study aimed to investigate the therapeutic effect of mesencephalic astrocyte-derived neurotrophic factor (MANF) on the MPTP/MPP+-induced model of Parkinson's disease (PD) and the…
  • 2018 International Congress

    Freezing of Gait in Parkinson’s Disease: Clinico-biochemical Observations

    B. Mondal, R. Banerjee, K. Chatterjee, A. Roy, S. Shubham, P. Basu, S. Choudhury, H. Kumar (Kolkata, India)

    Objective: We aimed to compare motor and non-motor functions, 2D-spatiotemporal gait parameters and serum oxidative markers including catalase (CAT), superoxide dismutase (SOD) and malondialdehyde (MDA)…
  • 2018 International Congress

    Protective effects of Mucuna pruriens seed on rat brain: A therapeutic potential drug for Parkinson’s disease

    S. Rajput, S. Sinha (New Delhi, India)

    Objective: Objective of present study was evaluate neuroprotective and antiparkinson effects of Mp seed extract on Parkinsons brain of rats. Background: Parkinson’s disease (PD) is…
  • 2017 International Congress

    Rice bran extract against animal model of Huntington’s disease: Possible role of neurotransmitters

    P. Kumar, N. Kaur (Bathinda, Punjab, India)

    Objective: The present study has been designed to explore the effect of rice bran extract against 3-NP induced neurotoxicity in rats.  Background: Huntington’s disease (HD)…
  • 2017 International Congress

    Analysis of serum non-mercaptoalbumin in patients with Parkinson’s disease

    S. Ueno, T. Hatano, Y. Ouji, S. Saiki, H. Ikeda, N. Hattori (Tokyo, Japan)

    Objective: It is well known that the oxidative stress might be associated with the pathomechanisms of Parkinson’s disease (PD). In this study, we assessed serum…
  • 2017 International Congress

    Increased bilirubin levels in Parkinson’s disease from southern Spain.

    D. Macias Garcia, D. Macias Garcia, C. Mendez Barrio, S. Jesus, M.A. Labrador Espinosa, M. Bernal Escudero, L. Vargas Gonzalez, A. Adarmes Gomez, F. Carrillo, M. Carballo, P. Gómez-Garre, P. Mir (Seville, Spain)

    Objective: To evaluate serum bilirubin concentration in Parkinson’s disease (PD) compared to healthy controls (HC) and to investigate its associations with motor and non-motor features…
  • « Previous Page
  • 1
  • …
  • 5
  • 6
  • 7
  • 8
  • 9
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley